Ratings Green Oleo S.p.A.

Equities

GRN

IT0005549768

Real-time Borsa Italiana Other stock markets 07:01:44 2024-05-20 am EDT			5-day change	1st Jan Change
0.94 ^EUR	+0.53%		+0.53%	-2.29%

May. 13	Business Square only in green; Stellantis on top	AN
May. 13	Mib only list in green; DiaSorin bullish	AN

Strengths

The stock, which is currently worth 2024 to 0.65 times its sales, is clearly overvalued in comparison with peers.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company has insufficient levels of profitability.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Diversified Chemicals

	1st Jan change	Capi.	ESG Refinitiv
GREEN OLEO S.P.A.	-2.29%	32.88M	-
SHIN-ETSU CHEMICAL CO., LTD.	+2.81%	75B	B
BASF SE	+0.92%	47.43B	A-
DUPONT DE NEMOURS, INC.	+3.87%	33.41B	C
PIDILITE INDUSTRIES LIMITED	+11.03%	18.41B	B
EASTMAN CHEMICAL COMPANY	+11.76%	11.8B	A-
SYENSQO SA/NV	+1.47%	10.97B	-
BRENNTAG SE	-16.44%	10.93B	B
ASAHI KASEI CORPORATION	+0.87%	9.26B	A-
SRF LIMITED	-8.12%	8.11B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes